Home/Pipeline/Arrhythmia Diagnosis & Management

Arrhythmia Diagnosis & Management

Induction/termination of SVT/Flutter; Differential diagnosis

CommercialActive

Key Facts

Indication
Induction/termination of SVT/Flutter; Differential diagnosis
Phase
Commercial
Status
Active
Company

About CardioCommand

CardioCommand is a private medical device company commercializing a patented transesophageal technology for cardiac pacing and monitoring. Its core TAP technology leverages the esophagus's proximity to the heart to provide a minimally invasive alternative for temporary atrial pacing, stress testing, and electrophysiology studies. The company's products are used by leading hospitals and medical centers across the United States, indicating established clinical adoption. While the initial data mentions a veterinary product (petMAP), the primary focus from the website is on human medical applications in anesthesia, cardiology, and electrophysiology.

View full company profile

Therapeutic Areas